Asia Pacific Varicose Vein Treatment Market was worth USD 65.79 million in 2019 and estimated to be growing at a CAGR of 6.9%, to reach USD 91.84 million by 2024 during the forecast period 2019-2024.
The varicose vein treatment market is driven by the increased prevalence of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders, and high blood pressure.
Asia Pacific varicose vein treatment market is anticipated to witness impressive growth in the near future owing to factors such as the surge in disposable income, improvement in healthcare infrastructure, increase in patient awareness about the advantage of seeking early treatment and rapid growth in aging population. However, the lack of trained vascular surgeons and expensive varicose vein treatment procedures can hinder the growth of this market.
This research report segmented and sub-segmented the Asia Pacific Varicose Vein Treatment Market into the following categories and evaluated market size and forecast to each segment until 2024.
By treatment Types: surgical treatments: Vein ligation and stripping, phlebectomy; non-surgical treatments: Laser Therapy, trans-illuminated powered phebectomy (trivex), Radiofrequency ablation; Sclerotherapy.
By Device: Ablation devices: Radiofrequency Ablation Devices, Laser Ablation Devices; Venous Closure Products, Surgical Products.
By End-User: Healthcare Industry: Surgery centers, Hospitals: Specialty hospitals, Multispecialty hospitals
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC
Prominent Companies in the Market:
Some of the Prominent Companies leading the Asia Pacific Varicose Vein Treatment Market Profiled in the Report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Treatment
5.1.1 Introduction
5.1.2 Endovenous ablation
5.1.3 Surgical litigation/ Stripping
5.1.4 Sclerotherapy
5.1.5 Y-o-Y Growth Analysis, By Treatment
5.1.6 Market Attractiveness Analysis, By Treatment
5.1.7 Market Share Analysis, By Treatment
5.2 Product
5.2.1 Introduction
5.2.2 Ablation devices
5.2.2.1 Radiofrequency ablation devices
5.2.2.2. Laser ablation devices
5.2.3 Venous closure products
5.2.4 Surgical products
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Treatment
6.1.3.3 By Product
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Treatment
6.1.4.3 By Product
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Treatment
6.1.5.3 By Product
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AngioDynamics, Inc.
8.3 Syneron Medical Ltd.
8.4 Lumenis Ltd.
8.5 Dornier MedTech GmbH
8.6 Energist Group
8.7 Vascular Solutions, Inc.
8.8 Merz Aesthetics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
